KOD
Companies
NASDAQ
Kodiak Sciences Inc.
Health Care
$3.53
-$6.33 (-63.67%)
Price Chart
Overview
About KOD
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Market Cap
$151.8M
Volume
1.3M
Avg. Volume
1.3M
P/E Ratio
-0.56842107
Dividend Yield
0.00%
Employees
106.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.06
High Correlation
Volatility
High (0.97)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KOD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$151.8M
Volume1.3M
P/E Ratio-0.57
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025